News

The patch, known as Daytrana, was licensed to Shire from its original developers Noven Pharmaceuticals, and is under review to treat attention deficit hyperactivity disorder (ADHD) in children

A priority review designation is assigned by the FDA for those applications that have the potential for providing a significant therapeutic advance. “Doctors treating patients with gastric cancer

FM-VP4 is a cholesterol absorption inhibitor, a new class in cholesterol-lowering drugs. The drug may have an application as a monotherapy or as a combination therapy with statins.

The agreement also settles the patent litigation relating to Barr’s generic version of the drug which its subsidiary Duramed Pharmaceuticals markets under the name Kariva. The deal includes

The FDA “approvable letter” is the second such setback that the company has suffered in its attempts to gain marketing approval for the drug in the US, and

The objectives of the trial are to determine safety, dose, pharmacokinetic profile and preliminary efficacy of Inno-105. The treatment is derived from a naturally occurring peptide that inhibits

While a number of studies published in the 1970s and 1980s indicated that small to moderate consumption of alcohol may help protect against heart disease, scientists at the

The collaboration will use Alder’s proprietary yeast production system and high throughput antibody selection system to identify and produce antibodies. Under terms of the agreement, Alder will work

The research and development is to be conducted in conjunction with researchers at the University of Pennsylvania, Duke University, and Beth Israel/Deaconess Hospital in Boston. Wyeth will develop